How college athletes line up tens of thousands of dollars in name, image and likeness deals

How college athletes line up tens of thousands of dollars in name, image and likeness deals


The NCAA enacted an interim name, image and likeness policy almost a year ago, which allows athletes — many of whom have big social media followings — to make deals with local car dealerships, and in some instances, with major retail and media brands.

Several states have written their own individual laws to regulate compensation in name, image and likeness, commonly known as NIL. Some states, though, have stayed on the proverbial sidelines. Meanwhile, the NCAA has asked Congress for federal legislation that lays out a framework that encompasses compensation for all college athletics.

“It was either an economics rights issue, a civil rights issue, a racial justice issue and, for some, all of those, that it was just unfair that these student-athletes were generating so much money but unable to be compensated for it,” said Gabe Feldman, a sports law professor at Tulane University.

Watch the video above to find out more about how college athletes have been using NIL deals to earn tens of thousands of dollars, the growing pushback against these policies, and what’s next for college athletes now that they can turn their fame into dollar signs.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More